Gabriel Steg Selected Research

Gabriel Steg Research Topics

Disease

13	Hemorrhage 02/2021 - 01/2010
10	Myocardial Infarction 01/2022 - 12/2002
10	Acute Coronary Syndrome 02/2021 - 04/2005
8	Stroke (Strokes) 01/2022 - 09/2012
6	ST Elevation Myocardial Infarction 06/2022 - 10/2009
5	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 04/2005
5	Thrombosis (Thrombus) 10/2016 - 03/2011
4	Heart Failure 08/2015 - 06/2003
2	Diabetes Mellitus 10/2016 - 08/2015
1	COVID-19 04/2022
1	Pneumonia (Pneumonitis) 04/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2021
1	MINOCA 11/2021
1	Chronic Renal Insufficiency 02/2021
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 12/2020
1	Overweight 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020
1	Thrombocytopenia (Thrombopenia) 12/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2016
1	Chest Pain (Chest Pains) 04/2016
1	Pain (Aches) 04/2016
1	Non-ST Elevated Myocardial Infarction 04/2016
1	Coronary Disease (Coronary Heart Disease) 02/2013
1	Infarction (Infarctions) 03/2011
1	Intermittent Claudication 11/2010
1	Hematoma 01/2010
1	Hypertension (High Blood Pressure) 05/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2009
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2009
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2009
1	Hypersensitivity (Allergy) 06/2008
1	Necrosis 04/2005
1	Dyspnea (Shortness of Breath) 06/2003
1	Atrioventricular Block 12/2002
1	Ischemia 12/2002
1	Ventricular Tachycardia 12/2002

Drug/Important Bio-Agent (IBA)

5	Clopidogrel (Plavix)FDA Link 11/2021 - 11/2011
5	TicagrelorIBA 02/2021 - 09/2012
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 06/2008
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 11/2021 - 01/2019
3	omega-Chloroacetophenone (Mace)IBA 01/2019 - 06/2013
3	Abciximab (ReoPro)FDA Link 02/2012 - 12/2002
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2006 - 06/2003
2	Hemoglobins (Hemoglobin)IBA 12/2021 - 01/2010
2	Prasugrel Hydrochloride FDA Link 02/2021 - 02/2013
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2016 - 02/2013
2	AnticoagulantsIBA 06/2013 - 10/2009
2	bivalirudin (Angiomax)FDA Link 08/2012 - 03/2011
2	Glycoproteins (Glycoprotein)IBA 07/2011 - 03/2011
2	Enoxaparin (Lovenox)FDA LinkGeneric 07/2011 - 01/2010
2	AntithrombinsIBA 07/2011 - 06/2008
1	Oxygen (Dioxygen)IBA 04/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2022
1	tocilizumab (atlizumab)FDA Link 04/2022
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2022
1	Glucagon-Like Peptide ReceptorsIBA 01/2022
1	Sodium-Glucose Transport ProteinsIBA 01/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022
1	LDL CholesterolIBA 12/2020
1	LipidsIBA 12/2020
1	RubidiumIBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 10/2016
1	zotarolimusIBA 10/2016
1	Morphine (MS Contin)FDA LinkGeneric 04/2016
1	Opioid Analgesics (Opioids)IBA 04/2016
1	Cytochrome P-450 CYP2C19IBA 04/2016
1	saxagliptin FDA Link 08/2015
1	Indicators and Reagents (Reagents)IBA 03/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2013
1	Purinergic P2Y Receptor AntagonistsIBA 02/2013
1	Fondaparinux (Arixtra)FDA Link 08/2012
1	Heparin (Liquaemin)FDA LinkGeneric 07/2011
1	Retinaldehyde (Retinal)IBA 05/2009
1	Pharmaceutical PreparationsIBA 01/2009
1	Biomarkers (Surrogate Marker)IBA 04/2005

Therapy/Procedure

12	Therapeutics 11/2021 - 12/2002
9	Percutaneous Coronary Intervention 06/2022 - 01/2010
4	Stents 10/2016 - 03/2011
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2011 - 12/2002
2	Thrombolytic Therapy 06/2008 - 12/2002
1	Artificial Respiration (Mechanical Ventilation) 04/2022
1	Blood Transfusion (Blood Transfusions) 01/2018
1	Length of Stay 08/2012
1	Thrombectomy 03/2011
1	Surgical Amputation (Amputations) 11/2010
1	Punctures 01/2010